↓ Skip to main content

Modulation of aberrant splicing in human RNA diseases by chemical compounds

Overview of attention for article published in Human Genetics, March 2017
Altmetric Badge

Citations

dimensions_citation
22 Dimensions

Readers on

mendeley
40 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Modulation of aberrant splicing in human RNA diseases by chemical compounds
Published in
Human Genetics, March 2017
DOI 10.1007/s00439-017-1789-4
Pubmed ID
Authors

Naoyuki Kataoka

Abstract

Pre-mRNA splicing is an essential step for gene expression in higher eukaryotes. Alternative splicing contributes to diversity of the expressed proteins from the limited number of genes. Disruption of splicing regulation often results in hereditary and sporadic diseases called as 'RNA diseases'. Modulation of splicing by small chemical compounds and nucleic acids has been tried to target aberrant splicing in those diseases. Several RNA diseases and splicing-target therapeutic approaches will be briefly introduced in this review. Accumulating knowledge about molecular mechanism of aberrant splicing and their correction by chemical compounds is important not only for RNA biologists, but also for clinicians who desire therapies for those diseases.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 40 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 40 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 9 23%
Researcher 9 23%
Student > Master 8 20%
Student > Bachelor 2 5%
Professor 2 5%
Other 2 5%
Unknown 8 20%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 10 25%
Agricultural and Biological Sciences 10 25%
Medicine and Dentistry 3 8%
Chemistry 2 5%
Nursing and Health Professions 1 3%
Other 3 8%
Unknown 11 28%